Zdrowie i gospodarka · 16/06/1997

FDA Extends Comment Period for Draft Guidance on Positron Emission Tomography Drug Products

The FDA is extending the comment period for its draft guidance on the content and format of abbreviated new drug applications for positron emission tomography (PET) drug products until August 27, 1997, in response to a request from the Institute for Clinical PET.